The
Pfizer’s pill to treat the disease caused by the coronavirus showed extraordinary results in a clinical trial, reducing hospitalization and death by 89% among high-risk Covid-19 patients. The company said Tuesday it
The administration has also ordered about 3.1 million courses of a pill from
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.